Wyeth has rallied more than 4% at Rs 1,015 in an otherwise weak market after reporting a net profit of Rs 42.49 crore for the quarter ended June 30. The company had posted a net profit of Rs 26.65 crore for the quarter ended May 31, 2010.
“Net sales of the company stood at Rs 146 crore for the quarter ended June 30, 2011. It was Rs 122 crore for the quarter ended May 31, 2010," the pharmaceutical company said in a filing to the Bombay Stock Exchange (BSE).
The figures are not comparable as the current quarter is from April 1, 2011 to June 30, 2011, while the previous quarter was from March 1, 2010 to May 31, 2010, Wyeth said.
The stock opened at Rs 970 and hit a high of Rs 1,020 on the NSE. A combined 7,604 shares have changed hands on the counter till 1019 hours.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
